0000950170-24-076384.txt : 20240621
0000950170-24-076384.hdr.sgml : 20240621
20240621180405
ACCESSION NUMBER: 0000950170-24-076384
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240621
FILED AS OF DATE: 20240621
DATE AS OF CHANGE: 20240621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boudreau Helen M
CENTRAL INDEX KEY: 0001661481
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39593
FILM NUMBER: 241061605
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Shattuck Labs, Inc.
CENTRAL INDEX KEY: 0001680367
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 812575858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 W. 5TH STREET
CITY: AUSTIN
STATE: TX
ZIP: 78701
BUSINESS PHONE: 512-900-4690
MAIL ADDRESS:
STREET 1: 500 W. 5TH STREET
CITY: AUSTIN
STATE: TX
ZIP: 78701
4
1
ownership.xml
4
X0508
4
2024-06-21
0001680367
Shattuck Labs, Inc.
STTK
0001661481
Boudreau Helen M
C/O SHATTUCK LABS, INC.
500 W. 5TH STREET, SUITE 1200
AUSTIN
TX
78701
true
false
false
false
false
Stock Option (Right to Buy)
4.37
2024-06-21
4
A
false
27700
0.00
A
2034-06-21
Common Stock
27700
27700
D
This option represents the right to purchase a total of 27,700 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.
/s/ Andrew R. Neill, Attorney-in-Fact for Helen M. Boudreau
2024-06-21